Oregon Medical Research Center

Clinical research site in Portland, Oregon · Oregon Medical Research Center, 1750 S Harbor Way #330, Portland, OR 97201 · (503) 245-1525 · Website

As of July 2026, 8 paid clinical trials are recruiting at Oregon Medical Research Center in Portland, Oregon. Active studies at this site cover conditions such as Plaque Psoriasis, Chronic Spontaneous Urticaria (CSU) and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Oregon Medical Research Center (8)

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for Plaque Psoriasis

97 locations incl. Birmingham

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 40+

Code: NCT07116967·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

for Chronic Spontaneous Urticaria (CSU)

128 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06868212·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

36 locations incl. Birmingham

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06158841·Phase 3·Recruiting·Listed Dec 2023

Apply to this trial

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

for Alopecia Areata

39 locations incl. Chula Vista

Sponsor: AbbVie

Sex: All·Age: 12 - 63

Code: NCT06012240·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

for Non-segmental Vitiligo

21 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 99

Code: NCT07431177·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

for Hidradenitis Suppurativa

15 locations incl. Scottsdale

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07244263·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

for Immunoglobulin Light Chain (AL) Amyloidosis

12 locations incl. Miami

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06158854·Phase 1, Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

for Cardiovascular

7 locations incl. Jacksonville

Sponsor: CRISPR Therapeutics AG

Sex: All·Age: 18 - 75

Code: NCT07491172·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

More research sites in Portland

Oregon Health and Science University (201 trials)
Oregon Health & Science University (161 trials)
Providence Portland Medical Center (117 trials)
Providence Saint Vincent Medical Center (90 trials)
OHSU Knight Cancer Institute (46 trials)
Providence St. Vincent Medical Center (24 trials)
VA Portland Health Care System, Portland, OR (22 trials)
Legacy Emanuel Children's Hospital (19 trials)
Oregon Health Sciences University (19 trials)
Oregon Health & Science University (OHSU) (19 trials)

Explore more

Paid clinical trials in Portland, OR · Oregon clinical trials